NCT02499952 2022-07-11Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell TumorsHoosier Cancer Research NetworkPhase 2 Terminated12 enrolled 14 charts
NCT01379534 2015-05-20A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial CancerNovartisPhase 2 Completed53 enrolled 10 charts
NCT00377520 2009-11-20A Trial for Patients With Advanced/Recurrent Endometrial CancerEli Lilly and CompanyPhase 2 Completed27 enrolled 10 charts